100% Secure Payments
Tender Details
- Country: USA
- Summary: Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial not Allowed)
- UST Ref No: 62823097
- Deadline: 17 Oct 2024
- Competition: ICB
- Financier: Self Financed
- Purchaser Ownership: -
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: PAR-22-101
- Purchaser's Detail :
- Description :
- Tender are invited for Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
CFDA Number : 93.350 -- National Center for Advancing Translational Sciences93.865 -- Child Health and Human Development Extramural Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Oct 17, 2024
Posted Date : Feb 03, 2022
Description: This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. The initiative seeks applications that are intended to facilitate rare diseases research by enabling efficient and effective movement of candidate therapeutics or diagnostics towards clinical trials, and to increase their likelihood of success through development and testing of rigorous biomarkers and clinical outcome assessment measures, or by defining the presentation and course of a rare disease to enable the design of upcoming clinical trials. - Documents :
Purchaser : NATIONAL INSTITUTES OF HEALTH
NIH OER WebmasterOERWebmaster03@od.nih.gov
Email :OERWebmaster03@od.nih.gov
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN
